Diabetes Research

Type 1 Diabetes Screening Can Give Families More Time
July 15, 2026
Join Trial Testing New Drug for Weight Management
A clinical trial is recruiting adults with type 2 diabetes to test a new long-lasting amylin drug for weight management.

Why Unapproved Peptides Are Risky
GLP-1 is a peptide proven to be an effective treatment for diabetes and weight management. However, taking any peptide that has not been approved as a medication is risky and potentially ineffective.

How To Cope With Diabetes Stigma at Work
Managing diabetes at work can mean balancing deadlines, meetings, glucose checks, and treatment while also dealing with comments from coworkers who don’t understand. Advocates and people with diabetes discuss how to respond – and why preventing stigma should not fall on people with diabetes alone.

Tzield (Teplizumab) to Delay Type 1 Diabetes
Tzield has been shown to delay the onset of type 1 diabetes by an average of two years. Here’s more about screening and whether treatment may be right for you.

Diabetes Technology Highlights From ADA 2026
At the American Diabetes Association's 2026 Scientific Sessions in New Orleans, tech updates were focused on making diabetes care more accessible and less disruptive.